...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: plenty of scenarios being put out there...
C'mon Kayaker...please work with me here and remember that's not my scenario...it's Don's. Whatever the revenues are it winds up being cash in your jeans. Be happy. PVLee
Share
New Message
Please login to post a reply